Colgate-Palmolive Q3 2024 10-Q Filed

Ticker: CL · Form: 10-Q · Filed: 2024-10-25T00:00:00.000Z

Sentiment: neutral

Topics: 10-Q, financials, debt

TL;DR

Colgate-Palmolive's Q3 2024 10-Q is in, showing debt details and financial performance.

AI Summary

Colgate-Palmolive Company filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter of 2024. Key financial instruments and debt obligations, including various notes due in 2026, 2029, 2034, and 2039, are referenced.

Why It Matters

This filing provides investors with the latest financial snapshot of Colgate-Palmolive, crucial for understanding the company's performance and financial health.

Risk Assessment

Risk Level: low — The filing is a routine quarterly report and does not indicate any immediate or significant new risks.

Key Numbers

Key Players & Entities

FAQ

What is the total value of Colgate-Palmolive's outstanding debt as of September 30, 2024?

The filing references specific debt instruments such as A0.500NotesDue2026Member, A0300NotesDue2029Member, A1.375NotesDue2034Member, and A0.875Notesdue2039Member, but the total aggregate debt value is not explicitly stated in the provided snippet.

What were the net sales for the third quarter of 2024?

The provided text does not contain specific figures for net sales for the third quarter of 2024.

What is Colgate-Palmolive's fiscal year end date?

Colgate-Palmolive's fiscal year ends on December 31st (1231).

What is the company's primary industry classification?

The company's Standard Industrial Classification is 'PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]'.

When was this 10-Q filing submitted to the SEC?

This 10-Q filing was submitted to the SEC on October 25, 2024.

Filing Stats: 4,835 words · 19 min read · ~16 pages · Grade level 17.9 · Accepted 2024-10-25 08:31:34

Key Financial Figures

Filing Documents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION COLGATE-PALMOLIVE COMPANY Condensed Consolidated Statements of Income (Dollars in Millions Except Per Share Amounts) (Unaudited) Three Months Ended Nine Months Ended September 30, September 30, 2024 2023 2024 2023 Net sales $ 5,033 $ 4,915 $ 15,156 $ 14,507 Cost of sales 1,959 2,038 5,977 6,131 Gross profit 3,074 2,877 9,179 8,376 Selling, general and administrative expenses 1,979 1,822 5,833 5,348 Other (income) expense, net 30 26 141 116 Operating profit 1,065 1,029 3,205 2,912 Non-service related postretirement costs 23 15 67 338 Interest (income) expense, net 56 58 175 170 Income before income taxes 986 956 2,963 2,404 Provision for income taxes 210 209 693 709 Net income including noncontrolling interests 776 747 2,270 1,695 Less: Net income attributable to noncontrolling interests 39 39 120 113 Net income attributable to Colgate-Palmolive Company $ 737 $ 708 $ 2,150 $ 1,582 Earnings per common share, basic $ 0.90 $ 0.86 $ 2.62 $ 1.91 Earnings per common share, diluted $ 0.90 $ 0.86 $ 2.61 $ 1.90 See Notes to Condensed Consolidated Financial Statements. 2 COLGATE-PALMOLIVE COMPANY Condensed Consolidated Statements of Comprehensive Income (Dollars in Millions) (Unaudited) Three Months Ended Nine Months Ended September 30, September 30, 2024 2023 2024 2023 Net income including noncontrolling interests $ 776 $ 747 $ 2,270 $ 1,695 Other comprehensive income (loss), net of tax: Cumulative translation adjustments 44 ( 79 ) ( 168 ) ( 9 ) Retirement plans and other retiree benefit adjustments 21 32 32 45 Gains (losses) on cash flow hedges ( 7 ) 5 ( 5 ) 1 Total Other comprehensive income (loss), net of tax 58 ( 42 ) ( 141 ) 37 Total Comprehensive income including noncontrolling interests 834 705 2,129 1,732 Less: Net income attributable to noncontrolling interests 39 39 120 113 Less: Cumulative translation adjustments attributable to noncontrolling interests 3 ( 3 ) ( 5 ) ( 44 ) Total Compreh

View on Read The Filing